Alkem Laboratories Limited

Alkem Labs Senior Management Personnel Vijay Shetty Resigns

Mr. Vijay Shetty, Senior Management Personnel at Alkem Laboratories Limited, has resigned. His cessation is effective December 12, 2025, to pursue other opportunities. Mr. Shetty was SVP – Global Distribution & Supply Chain.

Alkem Labs: Public Notice on Unclaimed Dividend Transfer to IEPF

Alkem Laboratories Limited issued a public notice for shareholders with unclaimed interim dividends from FY 2018-2019 onwards. Shares of those unclaimed for seven consecutive years will be transferred to the IEPF. Shareholders must submit claims to avoid transfer and potential loss of rights.

GMP Inspection by Malta Medicines Authority at Alkem's Daman facility

Malta Medicines Authority concluded GMP inspection at Alkem's Daman facility with no critical observations. The company will address the major and minor observations within the stipulated timeframe.

Alkem Laboratories informs about Analyst/Institutional Investor Meetings

Alkem Laboratories Limited announced meetings with Dalal & Broacha Portfolio Managers on December 12, 2025, and Yes Securities on December 15, 2025, in Mumbai.

Cessation of Senior Management Personnel - Mr. Rakesh Tripathi

Mr. Rakesh Tripathi resigned from Alkem Laboratories Limited due to personal commitments, effective December 8, 2025. The company acknowledged his contributions.

Alkem Laboratories Appoints Prakash Ramnani as Senior Management Personnel

Alkem Laboratories appoints Prakash Ramnani as senior management personnel effective December 5, 2025. Ramnani brings over 25 years of experience in pharmaceutical manufacturing.

Alkem Laboratories Receives GST Order from Uttarakhand Authority

Alkem Laboratories received a GST order demanding ₹27.14 lakh with a penalty of ₹27.79 lakh. The company will contest the order, believing there is no material impact.

Alkem Laboratories announces Analyst/Institutional Investor Meetings

Alkem Labs announces analyst/institutional investor meetings on December 9, 2025, including a virtual meeting with Capital Investment Trust Taiwan and an in-person meeting with Dalal & Broacha Portfolio Managers in Mumbai.

Alkem Laboratories Limited Announces Sustainability Report for FY 2024-2025

Alkem Laboratories Limited released its Sustainability Report for FY 2024-2025, showcasing initiatives in environmental stewardship, social responsibility, and governance. Key highlights include reduced emissions, energy consumption, and water usage.

Alkem Laboratories to attend Citi India Pharma & Healthcare Tour 2025

Alkem Laboratories will attend the Citi India Pharma & Healthcare Tour 2025 on 28 November 2025 in Mumbai.

GMP Inspection by Ministry of Health, Armenia at Alkem's Sikkim Facility

Ministry of Health, Armenia, conducted a GMP inspection at Alkem's Sikkim facility from November 21 to November 22, 2025. The inspection concluded with no critical or major observations.

Alkem launches probiotic “DSS” in India for gut health management

Alkem Laboratories launches DSS probiotic in India for gut health, a strategic addition to their gastrointestinal portfolio. CEO emphasizes commitment to innovative health solutions.

Alkem Labs Q2 & H1 FY26 Earnings Conference Call Transcript

Alkem Labs' Q2 & H1 FY26 earnings call transcript reveals strong revenue growth, particularly in India and the U.S. Management anticipates continued market outperformance and margin improvements despite new investments and GST impacts.

Alkem Laboratories Receives GST Order

Alkem Laboratories received a GST order demanding ₹1.81 crore plus penalty for alleged excess availment of Input Tax Credit. The company will contest the order, anticipating no material financial impact.

Alkem Laboratories Announces Unaudited Financial Results for Quarter Ended Sep 30, 2025

Alkem Laboratories announced its unaudited financial results for the quarter ended September 30, 2025, with a total income of ₹40,009.9 lakh and a net profit of ₹7,650.6 lakh.

Alkem Laboratories Limited Intimates Analyst/Investor Meetings

Alkem Laboratories Limited announced meetings with analysts and institutional investors between 20th November 2025 and 24th November 2025 in Mumbai.

Alkem Labs Q2 & H1FY26 Earnings Conference Call Audio Recording Available

Alkem Laboratories Limited has announced that the audio recording of its Q2 & H1FY26 Earnings Conference Call is now available on the company's website.

Trading Window Opens on 17 Nov 2025

Alkem Laboratories announces the opening of the trading window on November 17, 2025, following the communication of financial results for the quarter and half year ended September 30, 2025.

Alkem Laboratories Reports 17% Revenue Growth, 22% EBITDA Growth in Q2 FY26

Alkem Laboratories announced strong Q2 FY26 results with 17% revenue growth and 22% EBITDA growth. The company saw growth in India, US and international markets.

Alkem Laboratories Announces Q2 FY26 Results: Revenue Up 17%, EBITDA Up 22%

Alkem Laboratories announced its Q2 FY26 results with a 17% increase in revenue and a 22% increase in EBITDA. CEO Dr. Vikas Gupta highlighted robust growth across key markets and seamless adaptation to GST revisions.

Alkem Laboratories Approves Unaudited Financial Results for Quarter Ended Sep 30, 2025

Alkem Laboratories Limited approved the Standalone and Consolidated Unaudited Financial Results for the quarter and half year ended 30th September, 2025 in its board meeting held on 13th November, 2025.

Alkem Laboratories' Baddi facility receives clean EU GMP inspection from German Health Authority

Alkem's Baddi manufacturing facility received a clean EU GMP inspection by the German Health Authority, concluding with no critical or major observations, ensuring continued compliance.

Alkem Laboratories Receives Order Under GST Act

Alkem Laboratories received an order with a penalty of ₹2,16,263 under the GST Act due to alleged technical discrepancies. The company will contest the order and anticipates no material impact.

Alkem Foundation & IIT Bombay Collaborate to Establish Research Centre

Alkem Foundation and IIT Bombay collaborate to establish a research center for immuno-therapeutics and regenerative medicines, with Alkem Foundation funding a substantial portion of its CSR obligations over seven years.

Alkem & IIT Bombay collaborate for research center in immuno-therapeutics

Alkem Foundation and IIT Bombay collaborate to establish a research center for immuno-therapeutics and regenerative medicines, with Alkem Foundation contributing 20-25% of its CSR funds over seven years.

Alkem Laboratories to host conference call on Q2 and H1FY26 financial results

Alkem Laboratories will host a conference call on November 13, 2025, at 4:30 p.m. IST to discuss its Q2 and H1FY26 financial results with investors and analysts.

Alkem Laboratories Announces Conference Call for Q2 & H1FY26 Results

Alkem Laboratories announces a conference call to discuss Q2 and H1FY26 financial results on November 13, 2025, at 4:30 pm IST. The call will be hosted by Motilal Oswal Securities Ltd.

Alkem Laboratories receives GST demand order

Alkem Laboratories transfers trade generics business to wholly-owned subsidiary Alkem Wellness

Alkem Laboratories announces Senior Management Personnel Amit Ghare's resignation

Alkem Laboratories receives GST demand order

Alkem Laboratories Receives GST Demand Order

Alkem Launches Pertuza Biosimilar in India for HER2-Positive Breast Cancer

Alkem Labs to meet with Axis Capital Limited on 22nd September 2025.

Alkem Laboratories to hold meetings with analysts and investors.

Alkem Laboratories cancels Analyst/Investor meeting scheduled for 9th September 2025

Alkem Laboratories' 51st AGM Approves All Resolutions for FY25

Alkem Laboratories to hold meetings with HDFC MF and Schroders

Alkem Laboratories launches Olesoft Trucera, an advanced ceramide-boosting moisturizing lotion

Alkem Laboratories Q1 FY26: Revenue up 11.2%, EBITDA up 21.4%

Alkem Laboratories to attend Equirus Annual India Conference

Alkem Laboratories Q1FY26 Conference Call on August 12, 2025

Alkem Labs Receives Penalty Order under GST Act

Alkem Laboratories Announces 51st AGM and Reports Strong FY2025 Financial Performance